{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:14:15Z","timestamp":1791944055049,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.pcad.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T12:42:20Z","timestamp":1348404140000},"page":"218-228","source":"Crossref","is-referenced-by-count":104,"title":["Immune and inflammatory mechanisms in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"55","author":[{"given":"Hala","family":"El Chami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2012.07.006_bb0005","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0020","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0025","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(92)90238-7","article-title":"Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku","volume":"93","author":"Isern","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0035","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0040","doi-asserted-by":"crossref","first-page":"225S","DOI":"10.1378\/chest.114.3_Supplement.225S","article-title":"Primary pulmonary hypertension between inflammation and cancer","volume":"114","author":"Voelkel","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0045","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1183\/09031936.05.00045705","article-title":"Autoimmunity and pulmonary hypertension: a perspective","volume":"26","author":"Nicolls","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0050","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1378\/chest.114.1_Supplement.50S","article-title":"Chemokine macrophage inflammatory protein-1alpha mRNA expression in lung biopsy specimens of primary pulmonary hypertension","volume":"114","author":"Fartoukh","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0055","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.102.22.2720","article-title":"Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy","volume":"102","author":"Sakamaki","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0060","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfmuller","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0070","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.2106007","article-title":"CX(3)C chemokine fractalkine in pulmonary arterial hypertension","volume":"165","author":"Balabanian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00104706","article-title":"Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0080","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0085","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary arterial hypertension","volume":"165","author":"Dorfmuller","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0090","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1183\/09031936.00174908","article-title":"Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension","volume":"34","author":"Selimovic","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0095","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1378\/chest.08-2420","article-title":"Role for interleukin-6 in COPD-related pulmonary hypertension","volume":"136","author":"Chaouat","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0100","doi-asserted-by":"crossref","first-page":"572S","DOI":"10.1378\/chest.128.6_suppl.572S-a","article-title":"Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice","volume":"128","author":"Golembeski","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0105","doi-asserted-by":"crossref","unstructured":"Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009;104:236-244, 28p following 44.","DOI":"10.1161\/CIRCRESAHA.108.182014"},{"key":"10.1016\/j.pcad.2012.07.006_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-10-6","article-title":"Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice","volume":"10","author":"Savale","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.166.3906.753","article-title":"Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice","volume":"166","author":"Nishizuka","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.pcad.2012.07.006_bb0120","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.156.6.1577","article-title":"Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis","volume":"156","author":"Sakaguchi","year":"1982","journal-title":"J Exp Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000111548","article-title":"Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension","volume":"75","author":"Ulrich","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.pcad.2012.07.006_bb0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","article-title":"Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension","volume":"109","author":"Tamosiuniene","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0140","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1203\/01.pdr.0000250013.77008.28","article-title":"Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension","volume":"61","author":"Wedgwood","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0150","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.105.540542","article-title":"Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension","volume":"112","author":"Merklinger","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0155","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1096\/fj.07-8432com","article-title":"VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells","volume":"21","author":"Sakao","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0160","doi-asserted-by":"crossref","first-page":"L668","DOI":"10.1152\/ajplung.00491.2005","article-title":"Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension","volume":"291","author":"Taraseviciene-Stewart","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1165\/ajrcmb.18.6.2980","article-title":"Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension","volume":"18","author":"Christou","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)65137-1","article-title":"Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth","volume":"155","author":"Cool","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0272-5231(05)70280-X","article-title":"The pathobiology of pulmonary hypertension. Endothelium","volume":"22","author":"Tuder","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0180","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI117858","article-title":"Increased gene expression for VEGF and the VEGF receptors KDR\/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide","volume":"95","author":"Tuder","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0185","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200707-1037OC","article-title":"Platelet derived growth factor expression and function in idiopathic pulmonary arterial hypertension","author":"Perros","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0190","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/CIRCULATIONAHA.108.779751","article-title":"Combined tyrosine and serine\/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling","volume":"118","author":"Klein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0195","doi-asserted-by":"crossref","first-page":"L826","DOI":"10.1152\/ajplung.00199.2002","article-title":"Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus","volume":"284","author":"Balasubramaniam","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1513\/pats.200605-118SF","article-title":"Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?","volume":"3","author":"Morrell","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pcad.2012.07.006_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0210","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1161\/01.RES.88.1.e2","article-title":"Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension","volume":"88","author":"Yeager","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0215","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200707-1083OC","article-title":"Role of the TGF-beta\/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension","volume":"177","author":"Zaiman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0220","doi-asserted-by":"crossref","first-page":"L897","DOI":"10.1152\/ajplung.00044.2001","article-title":"Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells","volume":"282","author":"Quinn","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0225","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/01.RES.79.6.1131","article-title":"Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation","volume":"79","author":"Jones","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0230","first-page":"1349","article-title":"Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease","volume":"150","author":"Jones","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","article-title":"Vasoactive intestinal peptide: cardiovascular effects","volume":"49","author":"Henning","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0240","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"Petkov","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0245","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1113\/expphysiol.2008.042481","article-title":"Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung","volume":"93","author":"Janosi","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0196-9781(84)90228-6","article-title":"VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF)","volume":"5","author":"Cox","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.pcad.2012.07.006_bb0255","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00105807","article-title":"Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion","volume":"31","author":"Hamidi","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0260","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.106.681718","article-title":"Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene","volume":"115","author":"Said","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0265","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1203\/PDR.0b013e3181b33804","article-title":"Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets","volume":"66","author":"Vuckovic","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0270","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00050008","article-title":"Inhalation of vasoactive intestinal peptide in pulmonary hypertension","volume":"32","author":"Leuchte","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0703570","article-title":"5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension","volume":"131","author":"MacLean","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0280","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.RES.68.5.1362","article-title":"Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture","volume":"68","author":"Lee","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.84.3.329","article-title":"Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin","volume":"84","author":"Eddahibi","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0290","first-page":"L795","article-title":"A new role for an old molecule: serotonin as a mitogen","volume":"272","author":"Fanburg","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0295","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1378\/chest.121.3_suppl.97S-a","article-title":"Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension","volume":"121","author":"Eddahibi","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0300","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0305","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI8678","article-title":"Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene","volume":"105","author":"Eddahibi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2012.07.006_bb0310","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","article-title":"Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats","volume":"111","author":"Guignabert","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2466-9-19","article-title":"Gene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene","volume":"9","author":"Crona","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0320","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1161\/01.CIR.0000127375.56172.92","article-title":"Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension","volume":"109","author":"MacLean","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0325","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.RES.0000222546.45372.a0","article-title":"Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension","volume":"98","author":"Guignabert","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0330","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/CIRCULATIONAHA.108.767558","article-title":"Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice","volume":"117","author":"Dempsie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0335","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0340","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.RES.0000128406.08418.34","article-title":"NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction","volume":"94","author":"Rossow","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0345","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.RES.0000129701.14494.52","article-title":"Endothelin-1-dependent nuclear factor of activated T lymphocyte signaling associates with transcriptional coactivator p300 in the activation of the B cell leukemia-2 promoter in cardiac myocytes","volume":"94","author":"Kawamura","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0350","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/01.RES.0000077045.84609.9F","article-title":"NFATc3 and NFATc4 are required for cardiac development and mitochondrial function","volume":"92","author":"Bushdid","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2012.07.006_bb0355","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.0610467104","article-title":"The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted","volume":"104","author":"Bonnet","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2012.07.006_bb0360","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/hc0202.101974","article-title":"Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0365","doi-asserted-by":"crossref","first-page":"H570","DOI":"10.1152\/ajpheart.01324.2007","article-title":"Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer","volume":"294","author":"Archer","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0370","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.07.006_bb0375","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000195509","article-title":"Pulmonary artery pressure in rats with hereditary platelet function defect","volume":"54","author":"Kentera","year":"1988","journal-title":"Respiration"},{"key":"10.1016\/j.pcad.2012.07.006_bb0380","first-page":"768","article-title":"Enhanced expression of signal transducers and activators of transcription in lung tissue of hypoxic pulmonary hypertension rat models","volume":"42","author":"Wang","year":"2003","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.pcad.2012.07.006_bb0385","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pcad.2012.07.006_bb0390","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V96.6.2005","article-title":"Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3","volume":"96","author":"Kawamura","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pcad.2012.07.006_bb0395","doi-asserted-by":"crossref","first-page":"L137","DOI":"10.1152\/ajplung.00441.2002","article-title":"STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation","volume":"285","author":"Xu","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0400","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1096\/fj.04-2317fje","article-title":"Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension","volume":"18","author":"Xu","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0405","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0410","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.pcad.2012.07.006_bb0415","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.aids.0000327515.55041.da","article-title":"Mediators involved in HIV-related pulmonary arterial hypertension","volume":"22","author":"Humbert","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.pcad.2012.07.006_bb0420","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.4049\/jimmunol.150.10.4601","article-title":"Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120","volume":"150","author":"Ehrenreich","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0425","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200601-005OC","article-title":"HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques","volume":"174","author":"Marecki","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0430","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/aid.2009.0068","article-title":"Genetic characterization of HIV type 1 Nef-induced vesicle secretion","volume":"26","author":"Ali","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.pcad.2012.07.006_bb0435","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1128\/JVI.76.9.4625-4633.2002","article-title":"Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes","volume":"76","author":"Lundquist","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0440","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/viro.2000.0816","article-title":"HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway","volume":"282","author":"Swann","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.pcad.2012.07.006_bb0445","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/34929","article-title":"HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes","volume":"391","author":"Collins","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pcad.2012.07.006_bb0450","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4049\/jimmunol.170.4.1716","article-title":"HIV-1 Nef induces the release of inflammatory factors from human monocyte\/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation","volume":"170","author":"Olivetta","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0455","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780350114","article-title":"Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis","volume":"35","author":"Okano","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcad.2012.07.006_bb0460","first-page":"462","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0465","first-page":"1688","article-title":"Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis","volume":"22","author":"Fritzler","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0470","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1164\/ajrccm.155.1.9001324","article-title":"Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7","volume":"155","author":"Morse","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcad.2012.07.006_bb0475","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.2000.01320.x","article-title":"Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35","volume":"121","author":"Grigolo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0480","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2249.1999.00864.x","article-title":"Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein","volume":"116","author":"Okawa-Takatsuji","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pcad.2012.07.006_bb0485","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","article-title":"Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension","volume":"60","author":"Tamby","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.pcad.2012.07.006_bb0490","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcad.2012.07.006_bb0495","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","article-title":"Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension","volume":"28","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcad.2012.07.006_bb0500","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","article-title":"Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension","volume":"177","author":"Terrier","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062012001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062012001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T22:40:12Z","timestamp":1687732812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062012001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0033062012001302"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2012.07.006","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}